BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2025 Earnings Call Transcript November 3, 2025
BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.05866 EPS, expectations were $0.07.
Operator: Good day, and welcome to BioCryst Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Nick Wilder. Please go ahead.
Nick Wilder: Good morning, and welcome to...
